AI tool that helps omics researchers save months connecting data, freeing up time to curing illnesses.
Active Next round Seed Denmark AILast updated November 13, 2024
Kenneth Kastaniegaard, CEO
Kenneth has a PhD from Aalborg University along with a role as research assistant. He is a researcher, and has worked as such, before he co-founded Biogenity, also as the CEO.
Louis Loeb, CCO
Along with fellow co-founder Kenneth Kastaniegaard, Louis also co-founded Biogenity in the same role. As his fellow co-founders, is also a graduate of Aalborg University.
Patrick Østergaard, CTO
software developer with experience in both independent development, business operations, and customer communications. He has developed a Steam-available computer game before co-founding Omics Studio.
Established: 2024
Investment: 2024
Money raised: €296.000
Soft funding: €102.000
This has the potential to radically change the way scientists (especially non data scientists) work in these companies allowing for massive cost savings as the preparatory work leading to clinical trials can be vastly improved.